Covington & Burling advised ALK-Abelló A/S on the deal. ALK-Abelló A/S (ALK) and ARS Pharmaceuticals, Inc. (ARS Pharma) (Nasdaq: SPRY) announced a strategic license agreement. The...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here